The Next Generation of Microcarriers for Advanced Bioprocessing & Cell Delivery
In the rapidly evolving field of bioprocessing, CytoStrat® implantable microcarriers set a new standard. Designed to support seamless cell attachment, cell expansion, and clinical delivery of adherent cells, CytoStrat® microcarriers are engineered for scalability, efficiency, and enhanced functionality.
Whether for cell-based therapies, drug delivery, or medical devices, CytoStrat® transforms bioprocessing by reducing complexity and maximizing potency.
Unparalleled Innovation in Microcarrier Technology
Implantable Microcarriers
CytoStrat® microcarriers are uniquely designed for implantation, allowing for anchorage dependent cells to exist in natural states that enhance therapeutic outcomes.
Versatile microcarrier technology for bioprocessing
Surface modification, chemistry, stiffness, and porosity provide optimized attachment and growth of anchorage-dependent cell types, including MSCs, myoblasts, and iPSCs.
Bioprocessing Excellence
Our microcarriers streamline manufacturing by integrating into existing hardware while reducing manual cell manipulation. This leads to higher viability and consistency during bioprocessing.
Customized properties designed to mimic natural cell environments
Bespoke Design
Available as off-the-shelf or custom microcarriers with tunable composition, size (100 – 600 microns), stiffness, and porosity to meet individual bioprocessing needs.
Proven Safety
Clinically approved and biocompatible materials with no observed toxicity in human applications.
Scalable Manufacturing
From laboratory research to clinical trials, Luna Therapeutics offers flexible production capacities under GMP standards to meet R&D, bioprocess scale up or clinical trial needs.
Reduced Time-to-Market
Combining cells and microcarriers into a single implantable product, regulatory hurdles and bioprocessing steps are significantly minimized.
